Recently, the term premenstrual disorders (PMDs), which includes premenstrual syndrome
and premenstrual dysphoric disorder as a continuum, has been proposed. Although the …

Premenstrual dysphoric disorder (PMDD) is characterized by the predictable onset of mood
and physical symptoms secondary to gonadal steroid fluctuation during the luteal phase of …

Objective: Premenstrual dysphoric disorder (PMDD) is a common mood disorder,
characterized by distressing affective, behavioral, and somatic symptoms in the late luteal …

Premenstrual symptoms are experienced by many female individuals during their fertile age.
Premenstrual dysphoric disorder (PMDD), a sex-specific mood disorder, affects about 5% of …

Premenstrual dysphoric disorder (PMDD) is a psychiatric condition characterized by late
luteal phase affective, cognitive, and physical impairment. The disorder causes significant …

Abstract Introduction The European Medicines Agency has suspended the use of ulipristal
acetate (UPA) in the treatment of uterine fibroids and is reassessing its association with a …

Ulipristal acetate (UPA) was introduced as a novel progesterone receptor modulator as
effective therapy for symptomatic fibroids. Randomised clinical trials established its …

Uterine fibroids (leiomyomas or myomas) are the most frequent benign tumors in women.
Heavy menstrual bleeding with resultant anemia, dysmenorrhea, chronic pelvic pain …

Uterine fibroids are the most common benign neoplasm of the female reproductive tract in
reproductive age women. Their prevalence is age dependent and can be detected in up to …

Background Uterine fibroids are benign tumors that grow in or on the uterus of women.
Globally, they occur in more than 80% of women of African ancestry and 70% in white …